Based on recent data, Theriva Biologics, Inc. (TOVX) shows an Average True Range (ATR) of 0.02 and an Enterprise Value of -14.7M. Its average trading volume over the past 3 months is 12.77M, indicating liquidity. These fundamental metrics provide insight into TOVX's underlying financial health and market activity.
| ATR | 0.02 |
| Enterprise Value | -14.7M |
| Avg Vol (3 Months) | 12.77M |
| Avg Vol (10 Days) | 1.98M |
Theriva Biologics, Inc. (TOVX) technical indicators as of April 20, 2026: the SMA 20 is 3.89%, SMA 50 at -0.84%, and SMA 200 at -43.98%. The RSI 14 value is 50.88, suggesting its current momentum. These technical analysis signals help assess TOVX's price trends and potential future movements.
| SMA 20 | 3.89% |
| SMA 50 | -0.84% |
| SMA 200 | -43.98% |
| RSI 14 | 50.88 |
Theriva Biologics, Inc. (TOVX) stock performance overview as of April 20, 2026: The 52-week high is $1.5 (currently -86.87% below), and the 52-week low is $0.163 (currently 21.01% above). Over the past year, TOVX's performance is -87.34%, compared to the S&P 500's 25.03% change.
| 52-Week High | 1.5 |
| 52-Week High Chg | -86.87% |
| 52-Week Low | 0.1628 |
| 52-Week Low Chg | +21.01% |
| S&P 500 52-Week Chg | 25.03% |
According to market data, Theriva Biologics, Inc. (TOVX) stock's recent performance metrics show that over the last month, TOVX is -1.31%, with a Year-to-Date (YTD) performance of -13.97%. Over the past year, the stock has seen a -87.34% change. These figures summarize TOVX's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 0.2684 | 0.31 | 0.31 | 0.8632 | 1.5 | 0.31 |
| Low | 0.2213 | 0.1771 | 0.1628 | 0.1628 | 0.1628 | 0.1628 |
| Performance | -16.97% | -1.31% | -57.02% | -62.48% | -87.34% | -13.97% |
According to current financial data, TOVX stock's P/E (TTM) ratio is -0.12, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.22. Key valuation ratios for TOVX, including P/S (N/A), P/B (0.20), and P/FCF (-0.55), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | TOVX | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -0.12 | -1.22 | -5.12 | 32.59 |
| P/S (TTM) | N/A | 3.69 | 464.32 | 5.98 |
| P/B (TTM) | 0.2 | -148.27 | 0.65 | 4.99 |
| P/FCF (TTM) | -0.55 | 89.61 | -497.8 | 34.68 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep